/
Your selections:
Combining 5-azacitidine with the E-selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia
- Enjeti, Anoop K., Fogler, William E., Smith, Theodore A. G., Lincz, Lisa F., Bond, Danielle R., Magnani, John L.
Reporting bone marrow biopsies for myelodysplastic neoplasms and acute myeloid leukaemia incorporating WHO 5th edition and ICC 2022 classification systems: ALLG/RCPA joint committee consensus recommendations
- Ng, Ashley P., Adams, Rebecca, Tiong, Ing Soo, Seymour, Louise, Talaulikar, Dipti, Palfreyman, Emma, Enjeti, Anoop, Tate, Courtney
Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement
- Enjeti, Anoop K., Agarwal, Rishu, Singhal, Deepak, Tate, Courtney, Tiong, Ing Soo, Ross, David M., Blombery, Piers, Chee, Lynette, Chua, Chong Chyn, Grigg, Andrew, Hamad, Nada, Iland, Harry, Lane, Steven, Perkins, Andrew
Circulating microvesicles are less procoagulant and carry different miRNA cargo in myelodysplasia
- Enjeti, Anoop K., Ariyarajah, Anita, D'Crus, Angel, Riveros, Carlos, Seldon, Michael, Lincz, Lisa F.
Investigating the role of microparticles/ microvesicles/extracellular vesicles in vascular biology, haemostasis and haemopoietic dysregulation
- Enjeti, Anoop K.
Are you sure you would like to clear your session, including search history and login status?